Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 05, 2022 |
referred to higher education |
Jan 28, 2021 |
referred to higher education |
Assembly Bill A3717
2021-2022 Legislative Session
Sponsored By
STIRPE
Archive: Last Bill Status - In Assembly Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
William A. Barclay
Pamela J. Hunter
Kenneth Blankenbush
Donna Lupardo
2021-A3717 (ACTIVE) - Details
2021-A3717 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 3717 2021-2022 Regular Sessions I N A S S E M B L Y January 28, 2021 ___________ Introduced by M. of A. STIRPE, BARCLAY, HUNTER, BLANKENBUSH, LUPARDO -- read once and referred to the Committee on Higher Education AN ACT to amend the education law, in relation to the supervision of the manufacturing and repacking of certain medical gases or wholesaling of respiratory therapy agents THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 6808 of the education law is amended by adding a new subdivision 9 to read as follows: 9. SUPERVISION. WHOLESALERS WHO DO NOT REPACK MAY DESIGNATE AS THE SUPERVISOR A PERSON WHO PRESENTS EVIDENCE OF THE COMPLETION OF A MINIMUM OF TWO YEARS OF EDUCATION BEYOND HIGH SCHOOL AND WHO HAS AT LEAST TWO YEARS OF EXPERIENCE IN THE MANUFACTURING, REPACKING AND/OR WHOLESALING OF DRUGS SATISFACTORY TO THE STATE BOARD OF PHARMACY. ESTABLISHMENTS WHICH LIMIT THEIR OPERATION TO MANUFACTURING AND REPACKING OF COMPRESSED MEDICAL GASES AND/OR WHOLESALING OF RELATED RESPIRATORY THERAPY AGENTS SHALL HAVE EACH PERSON RESPONSIBLE FOR SUPERVISING THE MANUFACTURING, PROCESSING, PACKING, OR HOLDING OF A DRUG PRODUCT HAVE THE EDUCATION, TRAINING, AND EXPERIENCE, OR ANY COMBINATION THEREOF TO PERFORM ASSIGNED FUNCTIONS IN SUCH A MANNER AS TO PROVIDE ASSURANCE THAT THE DRUG PRODUCT HAS THE SAFETY, IDENTITY, STRENGTH, AND PURITY THAT IT PURPORTS TO POSSESS. § 2. This act shall take effect immediately. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD04721-01-1
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.